April 2013 FDA Recall Drug by Mylan Pharmaceuticals Inc.
D-500-2013 - Labeling

This Class II drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on April 22, 2013 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-500-2013

Reason for Recall
Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..
Initiated
04-22-2013
Reported
06-05-2013
Quantity
3,048 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mylan Pharmaceuticals Inc.
Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India

Batch or Lot Expiration Information

Lot# ZRMB11004, Exp 09/13